A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

NCT00077974 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
106
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer